Nota: La página que ha solicitado no está en su idioma predeterminado. Usted está usando nuestra plataforma en otro idioma ahora.

Respiratory devices with potential being modified to ventilators by company 2020

Published by
Conor Stewart,
Apr 9, 2020
Fisher & Paykel Healthcare has had eight respiratory devices approved between 2014 and March 2020 which could potentially be modified for ventilators through an Emergency Use Authorization. Due to the coronavirus pandemic (COVID-19) some hospitals already lack medical ventilators for patients in intensive care. One way to lower the burden is to modify other respiratory devices for ventilators.

Number of respiratory devices with potential to be modified for ventilators by Emergency Use Authorizations (EUAs) as of end-March 2020, by company*

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

March 2020

Region

United States

Survey time period

2014 to 31 March 2020

Supplementary notes

* Approvals from 2014 until the given date.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Coronavirus: the pharma and medtech response "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Coronavirus: the pharma and medtech response

Pharma - before the pandemic

6

Treatments and vaccines

8

Focus: BioNTech and Moderna

7

Opinions on COVID-19 vaccines

6

Business impact

4

Medtech - before the pandemic

5

Ventilators and testing

7

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Coronavirus COVID-19 in ChinaDiabetes in ChinaPharmaceutical industry in ChinaVaccine industry in ChinaFitness industry in China
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu